China Medicine Corp banner

China Medicine Corp
OTC:CHME

Watchlist Manager
China Medicine Corp Logo
China Medicine Corp
OTC:CHME
Watchlist
Price: 0.035 USD Market Closed
Market Cap: $974.4k

China Medicine Corp
Investor Relations

China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. The company is headquartered in Guangzhou, Guangdong and currently employs 281 full-time employees. The company went IPO on 2005-06-23. The firm is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The firm is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The firm's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The firm also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Senshan Yang
Chairman, CEO & Chairman of Guangzhou Konzern Medicine Co., Ltd
No Bio Available
Mr. Ho Chi Fung
Chief Financial Officer
No Bio Available
Ms. Huizhen Yu
Controller
No Bio Available

Contacts

Address
GUANGDONG
Guangzhou
Guangri Tower, Suite 702, No. 8 Siyou South 1St Street, Yuexiu District
Contacts
+862087391718.0
www.cmc621.com